FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-6500fje.
This Article
Right arrow Summary
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.06-6500fjev1
20/14/2582    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwakkenbos, M. J.
Right arrow Articles by Hamann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwakkenbos, M. J.
Right arrow Articles by Hamann, J.
(The FASEB Journal. 2006;20:2582-2584.)
© 2006 FASEB

An unusual mode of concerted evolution of the EGF-TM7 receptor chimera EMR2

Mark J. Kwakkenbos*,1, Mourad Matmati*,1, Ole Madsen{dagger},1, Walter Pouwels*, YongYi Wang*, Ronald E. Bontrop{ddagger}, Peter J. Heidt{ddagger}, Robert M. Hoek* and Jörg Hamann*,2

* Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands;

{dagger} Department of Biochemistry, Radboud University Nijmegen, Nijmegen, the Netherlands; and

{ddagger} Departments of Comparative Genetics and Refinement, and Animal Science, Biomedical Primate Research Centre, Rijswijk, The Netherlands

2Correspondence: Department of Experimental Immunology, K1–144, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. E-mail: j.hamann{at}amc.uva.nl

ABSTRACT

The epidermal growth factor (EGF)-TM7 receptors CD97, EMR1, EMR2, EMR3, and EMR4 form a group of adhesion class heptahelical molecules predominantly expressed by cells of the immune system. These receptors bind cellular ligands through EGF-like domains, localized N-terminal to a large extracellular region. Remarkably, EMR2 possesses a chimeric structure with a seven-span transmembrane (TM7) region most related to EMR3 and an EGF domain region nearly identical to CD97. By comparing EGF-TM7 receptors in primates and dogs, we identified an intriguing pattern of concerted evolution, apparently mediated by gene conversion, among EMR2 and the oppositely orientated and physically adjacent genes CD97 and EMR3. This concerted evolution has continuously maintained the chimeric structure of EMR2 since early mammal radiation. Most highly conserved between EMR2 and CD97 is the fourth EGF domain, which mediates binding to chondroitin sulfate, a ligand specificity shared by both receptors. Another ligand, CD55, is bound effectively only by CD97. We show that different molecular mechanisms (mutations vs. alternative splicing) prevent CD55 binding by EMR2 in hominoids. Our findings illustrate how various and partially opposing evolutionary events have shaped the structure and ligand specificity of a modern mammalian gene family.—Kwakkenbos, M. J., Matmati, M., Madsen, O., Pouwels, W., Wang, Y. Y., Bontrop, R. E., Heidt, P. J., Hoek, R. M., Hamann, J. An unusual mode of concerted evolution of the EGF-TM7 receptor chimera EMR2.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Q. Davies, G.-W. Chang, S. Yona, S. Gordon, M. Stacey, and H.-H. Lin
The Role of Receptor Oligomerization in Modulating the Expression and Function of Leukocyte Adhesion-G Protein-coupled Receptors
J. Biol. Chem., September 14, 2007; 282(37): 27343 - 27353.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.